Type I IFN (IFN-α) genetic polymorphisms and activity are associated with SLE pathogenesis (12) in lupus relatives (13), with enhanced IFN activity particularly associated with DNA- and RNA-protein binding autoantibody specificities (14, 15). This evidence concerns the gene IFNA1 and systemic lupus erythematosus.